Project factsheets

Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

Clear all filters

Displaying 13 projects/programmes

BD4BO

Big Data for Better Outcomes

c4c

conect4children - Collaborative network for European clinical trials for children

Ongoing IMI2 Clinical trial design Clinical networks Patient involvement in R&D Tools for pediatrics

EFOEUPATI

Ensuring the future of EUPATI beyond 2020

Closed IMI2 Patient involvement in R&D Education and training

EU-PEARL

EU patient-centric clinical trial platform

Ongoing IMI2 Diabetes & metabolic disorders Psychiatric diseases Infectious diseases Rare/orphan diseases Clinical trial design Clinical networks Patient involvement in R&D

EUPATI

European Patients' Academy on Therapeutic Innovation

Closed IMI1 Patient involvement in R&D Education and training

H2O

H2O Health outcomes observatory

Ongoing IMI2 Diabetes & metabolic disorders Autoimmune diseases Cancer Patient involvement in R&D Real-world data, evidence

IMI-PainCare

Improving the care of patients suffering from acute or chronic pain

Ongoing IMI2 Pain Tools for predicting/monitoring efficacy Patient involvement in R&D Disease taxonomy Imaging

MACUSTAR

Intermediate AMD: development of novel clinical endpoints for clinical trials in patients with a regulatory and patient access intention

Ongoing IMI2 Ageing-associated diseases Eye diseases Tools for predicting/monitoring efficacy Patient involvement in R&D Imaging

MOPEAD

Models of patient engagement for Alzheimer’s disease

Closed IMI2 Neurodegenerative diseases Alzheimer's disease Patient involvement in R&D

PARADIGM

Patients active in research and dialogues for an improved generation of medicines: advancing meaningful patient engagement in the life cycle of medicines for better health outcomes

Closed IMI2 Clinical trial design Patient involvement in R&D Regulatory and HTA processes

PREFER

Patient Preferences in benefit risk assessments during the drug life cycle

Closed IMI2 Clinical trial design Patient involvement in R&D Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment

SISAQOL-IMI

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

Ongoing IMI2 Cancer Clinical trial design Patient involvement in R&D Regulatory and HTA processes

SOPHIA

Stratification of obese phenotypes to optimize future obesity therapy

Ongoing IMI2 Diabetes & metabolic disorders Patient involvement in R&D Real-world data, evidence Disease taxonomy